Home
About
News
Careers
Contact
More
We are pioneering first-in-class, engineered IgA as neutrophil engagers to fight cancer.
Anne Altmeyer, PhD, MBA, MPH
CEO
Howard Stern, MD, PhD
CSO
Cassandra Choe-Juliak, MD, MS
CMO
Jeanette Leusen, PhD
Professor,
UMC Utrecht
Anne Altmeyer
Maarten de Jong
EQT
Sonia Gulati
Global BioAccess Fund
Dan McHugh
Yosemite
Edward van Wezel
BioGeneration Ventures